Dabigatran Etexilate
- Product NDC
- 72865-273
- 11-digit product format
- 728650273
- Labeler code
- 72865
- Product ID
- 72865-273_3f2f2d85-443a-46a1-a637-69b106156df4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dabigatran Etexilate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- XLCare Pharmaceuticals, Inc.
- Application
- ANDA207961
- Marketing category
- ANDA
- Marketing start
- 2023-08-01
- Substance
- DABIGATRAN ETEXILATE MESYLATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dabigatran Etexilate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DABIGATRAN ETEXILATE MESYLATE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SC7NUW5IIT |
| Rxcui | 1037045, 1037179 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72865-273-60 | Dabigatran Etexilate | 60 in 1 BOTTLE | CAPSULE | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72865-273 | DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE) CAPSULE [XLCARE PHARMACEUTICALS, INC.] | 1 | Current NDC, 1 package rows | 20240307_19b3bfc1-4fcb-4eb9-a611-02c27c05c56e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72865-273-60 | 72865027360 | 60 CAPSULE in 1 BOTTLE (72865-273-60) | 60 capsule | 2023-08-01 | No | No | Historical |